Skip to content

Case study

Commercial Assessment for a Gene Therapy Portfolio

Unlocking the Global Potential of Gene Therapy

An emerging biotech company advancing a portfolio of gene therapy candidates faced a pivotal question: in a world of limited resources, which pre-clinical candidates should we invest into for a clinical development. Akimbo Health provided the strategic insights needed to navigate this complex landscape.

Combining Research with Market Expertise

Akimbo began with in-depth secondary research to develop hypotheses about each program’s commercial potential. These were tested through interviews with key opinion leaders (KOLs) and payers across the US and EU, uncovering clinical usage patterns and pricing expectations. The team then modeled peak revenue scenarios, considering clinical trial design implications.

Driving Strategic Decisions with Data

The engagement provided the client with an evidence-based understanding of their market opportunity, complete with revenue scenarios and actionable recommendations. These insights enabled the company to make informed clinical development decisions and confidently approach potential partners.

Back To Top